Profile
Yuuwa Capital is a specialist life sciences commercialization and investment firm based in Western Australia, founded in 2009. It was established as the manager of a $40 million venture capital fund with support from the Australian Federal Government's Innovation Investment Fund and private investors. The firm is co-founded by Liddy McCall and James Williams, both of whom have extensive experience in early-stage startups in the life sciences sector. They bring decades of experience in founding, investing in, and managing biotech companies.
Yuuwa Capital focuses on the life sciences sector, providing both expertise and capital to identify and scale early-stage ventures. Their investments are targeted at early-stage opportunities, helping to start and grow companies in this space. The firm connects specialist early-stage investors with promising ventures but does not have an explicit stage or region focus on the site beyond being centered in Australia.
Notable companies in Yuuwa Capital's portfolio include AdAlta Limited, Agworld Pty Ltd, Fitgenes Australia Limited, iCeutica Inc (acquired), and Dimerix Limited. These investments highlight Yuuwa's focus on biotechnology and life sciences, with a track record of involvement in companies that achieve FDA approval and ASX listing.
Industry
Contacts
Instant access on the web. Plans from $129/month — see pricing.